Company intelligence / Profile preview

Rex Health Ventures

Raleigh, North Carolina, United States

Ownership: Private
Employees: ~2
Development stage: Other

Overview

Rex Health Ventures is the early-stage investment arm of UNC Health and UNC REX Healthcare, focusing on investing in and partnering with companies developing innovative healthcare technologies, products, and services to improve patient care. The group has an active investment portfolio in medical devices, health IT, diagnostics, and select biopharma platforms[1][2][5].

Industry: Investors

Partnerships

UNC Health/UNC REX Healthcare[1][2]Portfolio companies include: Arrivo BioVentures, Baebies, Bio54, Synaptrix, GI Windows Surgical, 410 Medical, Carta Healthcare[5]

Beyond the preview

Go deeper on Rex Health Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rex Health Ventures.

Explore the full profile